Indication and Practical Utilization of IV and Subcutaneous Biologics
Jill Zouzoulas, MD, FACR, opens a discussion highlighting use of biologics in her practice.
Video content above is prompted by the following:
- How long have you been using IV biologics in your practice, for which indications, and what has your overall experience been like?
- How long have you been using subcutaneous biologics in your practice, for which indications, and what has your overall experience been like?
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
October 7th 2024Jill Zouzoulas, M.D., of Tryon Medical Partners in Charlotte, North Carolina, and Jennifer Seminerio, M.D., of University of Southern Florida Health in Tampa, Florida, discussed the biologics and the pros and cons of the intravenous and subcutaneous delivery methods in Managed Healthcare Executive’s K-Cast video series.
Read More
Value-Based Decision-Making in Metastatic Breast Cancer
September 16th 2021In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.
Read More
